Mon, Sep 29, 2025
Volume 9, Issue 3 (Summer 2023)
Caspian J Neurol Sci 2023, 9(3): 193-199 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Soltani M, Salimnia N, Nahayati M A, Payere M. Case Series of Cerebral Venous Sinus Thrombosis After COVID-19 Vaccination. Caspian J Neurol Sci 2023; 9 (3) :193-199
URL: http://cjns.gums.ac.ir/article-1-644-en.html
URL: http://cjns.gums.ac.ir/article-1-644-en.html
1- Department of Neurology, Faculty of Medicine, Qaem Hospital, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract: (1172 Views)
Background: While care for COVID-19 patients has improved with clinical experience, there
remains a critical and unmet medical need for vaccines suitable to help or alleviate COVID-19
infections during the pandemic. Although the available vaccines have some benign autoimmune
side effects, such as mild thrombocytopenia, in rare cases, the side effects, such as central vein
thrombosis, severe thrombocytopenia, and intracranial hemorrhage, are life-threatening.
Case Presentation: We report 3 female patients (19, 24, and 43 years old) who developed cerebral
venous sinus thrombosis (CVST) after the AstraZeneca ChAdOx1-S COVID-19 vaccination.
Despite medical and surgical treatment, they finally became brain dead.
Conclusion: Medical professionals should know the manifestations and diagnostic methods of
CVST after the COVID-19 vaccination and how to properly treat and manage it.
remains a critical and unmet medical need for vaccines suitable to help or alleviate COVID-19
infections during the pandemic. Although the available vaccines have some benign autoimmune
side effects, such as mild thrombocytopenia, in rare cases, the side effects, such as central vein
thrombosis, severe thrombocytopenia, and intracranial hemorrhage, are life-threatening.
Case Presentation: We report 3 female patients (19, 24, and 43 years old) who developed cerebral
venous sinus thrombosis (CVST) after the AstraZeneca ChAdOx1-S COVID-19 vaccination.
Despite medical and surgical treatment, they finally became brain dead.
Conclusion: Medical professionals should know the manifestations and diagnostic methods of
CVST after the COVID-19 vaccination and how to properly treat and manage it.
Type of Study: case report |
Subject:
Special
Received: 2023/07/5 | Accepted: 2023/07/28 | Published: 2023/07/28
Received: 2023/07/5 | Accepted: 2023/07/28 | Published: 2023/07/28
| Rights and permissions | |
 | This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
